Terug
Dagbereik
€ 22,84
€ 24,60
52-Weeksbereik
€ 13,36
€ 27,55
Volume
170.855
50D / 200D Gem.
€ 23,15
/
€ 19,54
Vorige Slotkoers
€ 23,37
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,7 | 0,2 |
| P/B | — | 3,0 |
| ROE % | — | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 33,33
+37.7%
Low: € 31,00
High: € 35,00
Forward WPA
-€ 4,05
Omzet Sch.
0,0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
-€ 4,59
-€ 6,12 – -€ 3,05
|
0,0 | 2 |
| FY2027 |
-€ 3,89
-€ 4,68 – -€ 3,10
|
0,0 | 2 |
| FY2026 |
-€ 4,05
-€ 5,08 – -€ 3,25
|
0,0 | 3 |
No quarterly estimates available
Earnings Surprises
Last 1 quarter
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-06 | -€ 0,57 | -€ 0,61 | -7,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Negative free cash flow of -53,82M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio3,56
Interest Coverage0,00
Waardering
P/E Ratio
-9,71
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -63,10M |
| ROE | N/A | ROA | -188,17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -53,82M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3,56 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9,71 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,79% | ||
| Market Cap | 612,49M | Enterprise Value | 593,22M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 |
| Net Income | -63,10M | -6,28M | -14,35M |
| EPS (Diluted) | -17,83 | -1,77 | -4,05 |
| Gross Profit | 0,0 | 0,0 | 0,0 |
| Operating Income | -64,83M | -11,38M | -2,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 33,53M | 45,66M | 21,49M |
| Total Liabilities | 128,09M | 80,13M | 50,30M |
| Shareholders' Equity | -94,55M | -34,47M | -28,81M |
| Total Debt | 3,70M | 0,0 | 24,15M |
| Cash & Equivalents | 22,98M | 14,98M | 21,40M |
| Current Assets | 28,88M | 45,63M | 21,49M |
| Current Liabilities | 8,11M | 2,61M | 469.000,0 |